West Pharmaceutical (WST) PT Raised to $310 at Barclays
Barclays analyst Luke Sergott raised the price target on West Pharmaceutical (NYSE: WST) to $310.00 (from $275.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
